Non-Corticosteroid Eosinophil-Lowering Agents for Treatment of Eosinophilic Gastrointestinal Disorders (EGIDs)

被引:0
|
作者
Lee, J. [1 ]
Butterfield, J. H. [1 ]
Alexander, J. [1 ]
Weiler, C. R. [1 ]
机构
[1] Mayo Clin, Coll Med, Rochester, MN USA
关键词
D O I
10.1016/j.jaci.2008.12.955
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
958
引用
收藏
页码:S247 / S247
页数:1
相关论文
共 50 条
  • [21] Anti-IgE treatment of eosinophil-associated gastrointestinal disorders
    Foroughi, Shabnam
    Foster, Barbara
    Kim, NaYoung
    Bernardino, Leigh B.
    Scott, Linda M.
    Hamilton, Robert G.
    Metcalfe, Dean D.
    Mannon, Peter J.
    Prussin, Calman
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 594 - 601
  • [22] A Case Series on the Use of Dupilumab for Treatment of Refractory Eosinophilic Gastrointestinal Disorders
    Patel, Naiya
    Goyal, Aakash
    Thaker, Ameet
    Troendle, David
    Parrish, Christopher
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (02): : 192 - 195
  • [24] A Marked Eosinophilic Infiltration in Mucosa Could Be a Better Predictive Factor for Intractable Non-Esophageal Eosinophilic Gastrointestinal Disorders
    Ishihara, Shingo
    Kuribayashi, Shiko
    Sato, Keigo
    Kudo, Tomohiro
    Yamazaki, Setsuo
    Inoue, Teruki
    Hazama, Yoichi
    Furuya, Kensuke
    Nakayama, Tetsuo
    Hachisu, Yoko
    Marubashi, Kyoko
    Uraoka, Toshio
    [J]. DIGESTION, 2023, 104 (05) : 348 - 356
  • [25] A MARKED EOSINOPHILIC INFILTRATION IN MUCOSA COULD BE A BETTER PREDICTIVE FACTOR OF INTRACTABLE NON-ESOPHAGEAL EOSINOPHILIC GASTROINTESTINAL DISORDERS
    Ishihara, Shingo
    Kuribayashi, Shiko
    Sato, Keigo
    Kudo, Tomohiro
    Yamazaki, Setsuo
    Inoue, Teruki
    Hazama, Yoichi
    Furuya, Kensuke
    Nakayama, Tetsuo
    Hachisu, Yoko
    Marubashi, Kyoko
    Uraoka, Toshio
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1061 - S1062
  • [26] Does Dietary Treatment for Eosinophilic Gastrointestinal Disorders Impact Health Related Quality of Life?
    Taft, Tiffany
    Keefer, Laurie
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S675 - S676
  • [27] Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders
    Kindt, S.
    Tack, J.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2007, 19 : 32 - 39
  • [28] Successful Use of Plasma Exchange in the Treatment of Corticosteroid-Refractory Eosinophilic Granulomatosis with Polyangiitis Associated with Gastrointestinal Manifestations
    Tsujimoto, Kohei
    Yagita, Masato
    Taniguchi, Masashi
    Fujita, Masaaki
    [J]. CASE REPORTS IN IMMUNOLOGY, 2016, 2016
  • [29] Dupilumab Leads to Clinical Improvements including the Acquisition of Tolerance to Causative Foods in Non-Eosinophilic Esophagitis Eosinophilic Gastrointestinal Disorders
    Arakawa, Naoya
    Yagi, Hisako
    Shimizu, Mariko
    Shigeta, Daisuke
    Shimizu, Akihiko
    Nomura, Shigeru
    Takizawa, Takumi
    Yamada, Yoshiyuki
    [J]. BIOMOLECULES, 2023, 13 (01)
  • [30] Non-esophageal Eosinophilic Gastrointestinal Disorders with Blood Hypereosinophilia: A 10year Retrospective Review of Clinical Features and Treatment Regimens
    Lu, Angela
    Dages, Kelley
    Voelker, Dayne
    Bachman, Kay
    McBane, Robert, III
    Patten, Eboni
    Chiarella, Sergio
    Pongdee, Thanai
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB197 - AB197